A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the longer-term glycemic effect of two medicines approved for
initial treatment of type 2 diabetes. The study consists of a 2 week screening period (2
study visits), followed by an 80 week double-blind treatment period (11 study visits). Also,
a sub-study was included to look at changes in bone mineral density (BMD) at the lumbar
spine.